Visceral Leishmaniasis Market Report 2026
Download Free Sample Buy Now
Visceral Leishmaniasis Market Global Report 2026 Market Report Infographic Image

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Visceral Leishmaniasis Market Report 2026

Global Outlook – By Treatment (Antiparasitic, Antifungal, Other Treatments), By Diagnosis Method (Serological Tests, Molecular Tests, Microscopy, Culture Methods), By Route Of Administration (Oral, Injectable, Other Routes Of Administration), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), By End-User (Hospitals, Homecare, Specialty Clinics, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Visceral Leishmaniasis Market Overview

• Visceral Leishmaniasis market size has reached to $1.06 billion in 2025

• Expected to grow to $1.39 billion in 2030 at a compound annual growth rate (CAGR) of 5.5%

• Growth Driver: Rising Global Malnutrition Intensifies Vulnerability To Market Due To Immune System Weakening

• Market Trend: Advancements In Oral Antiparasitic Therapies For Visceral Leishmaniasis

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Visceral Leishmaniasis Market?

Visceral leishmaniasis, also known as kala-azar, is a severe parasitic disease caused by Leishmania species, transmitted through infected sandfly bites. It affects internal organs such as the spleen, liver and bone marrow, causing prolonged fever, weight loss, anemia and organ enlargement. If untreated, it can be fatal, making early diagnosis and treatment crucial.

The main treatment types of visceral leishmaniasis are antiparasitic, antifungal, and others. Antiparasitic refers to medications or treatments that specifically target and eliminate parasites from the body by disrupting their biological processes, preventing their growth, reproduction, or survival. It is diagnosed with various diagnostic methods such as serological tests, molecular tests, microscopy, and culture methods, and administered through several routes of administration consisting of oral, injectable, and other alternative methods. The distribution channels encompass hospital pharmacies, online pharmacies, and retail pharmacies and are used by various end users, including hospitals, home care, specialty clinics, and others.

Visceral Leishmaniasis Market Global Report 2026 Market Report bar graph

What Is The Visceral Leishmaniasis Market Size and Share 2026?

The visceral leishmaniasis market size has grown strongly in recent years. It will grow from $1.06 billion in 2025 to $1.12 billion in 2026 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to expansion of endemic disease prevalence, increasing public health awareness initiatives, availability of established antiparasitic treatments, growth of hospital-based treatment programs, international health organization support.

What Is The Visceral Leishmaniasis Market Growth Forecast?

The visceral leishmaniasis market size is expected to see strong growth in the next few years. It will grow to $1.39 billion in 2030 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to increasing investments in novel therapeutics, rising focus on vaccine and immunotherapy development, expansion of molecular diagnostic adoption, growing government funding for disease elimination, increasing access to treatment in endemic regions. Major trends in the forecast period include increasing adoption of advanced diagnostic techniques, rising use of combination drug therapies, growing focus on early disease detection, expansion of public health screening programs, enhanced investment in treatment accessibility.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Visceral Leishmaniasis Market Segmentation

1) By Treatment: Antiparasitic, Antifungal, Other Treatments

2) By Diagnosis Method: Serological Tests, Molecular Tests, Microscopy, Culture Methods

3) By Route Of Administration: Oral, Injectable, Other Routes Of Administration

4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

5) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users

Subsegments:

1) By Antiparasitic: Pentavalent Antimonials, Miltefosine, Paromomycin, Sitamaquine, Combination Therapy

2) By Antifungal: Amphotericin B, Liposomal Amphotericin B (AmBisome), Azoles, Echinocandins, Polyenes

3) By Other Treatments: Immunotherapy, Monoclonal Antibodies, Vaccine-Based Approaches, Photodynamic Therapy, Gene Therapy

What Is The Driver Of The Visceral Leishmaniasis Market?

The rise in malnutrition is expected to propel the growth of the visceral leishmaniasis market going forward. Malnutrition is a health condition resulting from inadequate or imbalanced nutrient intake required for healthy physiological functioning. The rise in malnutrition is due to food insecurity, as it limits access to nutritious food, leading to undernourishment and micronutrient deficiencies, which weaken the immune system. Malnutrition impairs immune function, making the body more vulnerable to infections such as visceral leishmaniasis. Nutrient deficiencies weaken defense mechanisms, increasing the risk of severe disease and complications. For instance, in July 2024, according to the United Nations Children's Fund (UNICEF), a U.S.-based specialized agency, around 733 million people were undernourished globally in 2023. Therefore, the rise in malnutrition is driving the growth of the visceral leishmaniasis industry.

Key Players In The Global Visceral Leishmaniasis Market

Major companies operating in the visceral leishmaniasis market are Pfizer Inc., GSK plc, Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories, Aurobindo Pharma Limited, Cipla Limited, Zydus Lifesciences Limited, Glenmark Pharmaceuticals Limited, Alkem Laboratories Ltd., Xellia Pharmaceuticals, Gufic Biosciences Ltd., United Biotech Private Limited, DNDi, Sanofi SA, Bharat Serums and Vaccines Limited, Emcure Pharmaceuticals Limited, Hetero Drugs Limited, Lupin Limited, Ipca Laboratories Limited, Intas Pharmaceuticals Limited, Macleods Pharmaceuticals Limited, Mankind Pharma Limited, Alembic Pharmaceuticals Limited

Global Visceral Leishmaniasis Market Trends and Insights

Major companies operating in the visceral leishmaniasis market are focusing on developing advancements in treatment options, such as antiparasitic drugs to improve efficacy and enhance patient accessibility, particularly in endemic regions. Antiparasitic drugs are medications used to treat infections caused by parasites, by targeting the parasite’s biological functions and disrupting its growth, reproduction, or survival within the host. For instance, in February 2024, Zydus Lifesciences Limited, an India-based pharmaceutical company, received World Health Organization (WHO) prequalification approval for the active pharmaceutical ingredient (API) and formulation of miltefosine for the treatment of leishmaniasis or kala-azar. Miltefosine is an oral antiparasitic drug that works by disrupting the parasite's cell membrane and interfering with its metabolism, leading to cell death. It also inhibits parasite growth and survival, making it an effective oral treatment option for visceral leishmaniasis or kala azar.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Visceral Leishmaniasis Market?

In January 2023, Gilead Sciences Inc., a US-based biopharmaceutical company that provides treatment for visceral leishmaniasis, extended its partnership with the World Health Organization (WHO) to facilitate better access to treatment options for visceral leishmaniasis. Through this partnership, Gilead Sciences is donating 304,700 vials of AmBisome (liposomal amphotericin B) to enhance the availability of essential medicines for the treatment of visceral leishmaniasis in high-burden countries, supporting global efforts to control and eliminate this life-threatening disease. The World Health Organization (WHO) is a Switzerland-based specialized agency that plays a key role in preventing, controlling, and eradicating visceral leishmaniasis through strategic initiatives and global health programs.

Regional Outlook

North America was the largest region in the visceral leishmaniasis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Visceral Leishmaniasis Market?

The visceral leishmaniasis market consists of revenues earned by entities by providing services such as drug development and distribution, vector control programs, and research and clinical trials. The market value includes the value of related goods sold by the service provider or included within the service offering. The visceral leishmaniasis market also includes sales of antileishmanial drugs, vaccines, vector control insecticides, recombinant antigen-based diagnostics, and polymerase chain reaction (PCR)-based detection kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Visceral Leishmaniasis Market Report 2026?

The visceral leishmaniasis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the visceral leishmaniasis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Visceral Leishmaniasis Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $1.12 billion
Revenue Forecast In 2035 $1.39 billion
Growth Rate CAGR of 5.9% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Treatment, Diagnosis Method, Route Of Administration, Distribution Channel, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Pfizer Inc., GSK plc, Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories, Aurobindo Pharma Limited, Cipla Limited, Zydus Lifesciences Limited, Glenmark Pharmaceuticals Limited, Alkem Laboratories Ltd., Xellia Pharmaceuticals, Gufic Biosciences Ltd., United Biotech Private Limited, DNDi, Sanofi SA, Bharat Serums and Vaccines Limited, Emcure Pharmaceuticals Limited, Hetero Drugs Limited, Lupin Limited, Ipca Laboratories Limited, Intas Pharmaceuticals Limited, Macleods Pharmaceuticals Limited, Mankind Pharma Limited, Alembic Pharmaceuticals Limited
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Visceral Leishmaniasis Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Visceral Leishmaniasis Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Visceral Leishmaniasis Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Visceral Leishmaniasis Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Sustainability, Climate Tech & Circular Economy

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.5 Artificial Intelligence & Autonomous Intelligence

4.2. Major Trends

4.2.1 Increasing Adoption Of Advanced Diagnostic Techniques

4.2.2 Rising Use Of Combination Drug Therapies

4.2.3 Growing Focus On Early Disease Detection

4.2.4 Expansion Of Public Health Screening Programs

4.2.5 Enhanced Investment In Treatment Accessibility

5. Visceral Leishmaniasis Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Clinics

5.3 Homecare Providers

5.4 Diagnostic Laboratories

5.5 Public Health Organizations

6. Visceral Leishmaniasis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Visceral Leishmaniasis Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Visceral Leishmaniasis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Visceral Leishmaniasis Market Size, Comparisons And Growth Rate Analysis

7.3. Global Visceral Leishmaniasis Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Visceral Leishmaniasis Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Visceral Leishmaniasis Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Visceral Leishmaniasis Market Segmentation

9.1. Global Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Antiparasitic, Antifungal, Other Treatments

9.2. Global Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Serological Tests, Molecular Tests, Microscopy, Culture Methods

9.3. Global Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Injectable, Other Routes Of Administration

9.4. Global Visceral Leishmaniasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

9.5. Global Visceral Leishmaniasis Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Homecare, Specialty Clinics, Other End-Users

9.6. Global Visceral Leishmaniasis Market, Sub-Segmentation Of Antiparasitic, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pentavalent Antimonials, Miltefosine, Paromomycin, Sitamaquine, Combination Therapy

9.7. Global Visceral Leishmaniasis Market, Sub-Segmentation Of Antifungal, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Amphotericin B, Liposomal Amphotericin B (AmBisome), Azoles, Echinocandins, Polyenes

9.8. Global Visceral Leishmaniasis Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Immunotherapy, Monoclonal Antibodies, Vaccine-Based Approaches, Photodynamic Therapy, Gene Therapy

10. Visceral Leishmaniasis Market Regional And Country Analysis

10.1. Global Visceral Leishmaniasis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Visceral Leishmaniasis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Visceral Leishmaniasis Market

11.1. Asia-Pacific Visceral Leishmaniasis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Visceral Leishmaniasis Market, Segmentation By Treatment, Segmentation By Diagnosis Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Visceral Leishmaniasis Market

12.1. China Visceral Leishmaniasis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Visceral Leishmaniasis Market, Segmentation By Treatment, Segmentation By Diagnosis Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Visceral Leishmaniasis Market

13.1. India Visceral Leishmaniasis Market, Segmentation By Treatment, Segmentation By Diagnosis Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Visceral Leishmaniasis Market

14.1. Japan Visceral Leishmaniasis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Visceral Leishmaniasis Market, Segmentation By Treatment, Segmentation By Diagnosis Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Visceral Leishmaniasis Market

15.1. Australia Visceral Leishmaniasis Market, Segmentation By Treatment, Segmentation By Diagnosis Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Visceral Leishmaniasis Market

16.1. Indonesia Visceral Leishmaniasis Market, Segmentation By Treatment, Segmentation By Diagnosis Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Visceral Leishmaniasis Market

17.1. South Korea Visceral Leishmaniasis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Visceral Leishmaniasis Market, Segmentation By Treatment, Segmentation By Diagnosis Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Visceral Leishmaniasis Market

18.1. Taiwan Visceral Leishmaniasis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Visceral Leishmaniasis Market, Segmentation By Treatment, Segmentation By Diagnosis Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Visceral Leishmaniasis Market

19.1. South East Asia Visceral Leishmaniasis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Visceral Leishmaniasis Market, Segmentation By Treatment, Segmentation By Diagnosis Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Visceral Leishmaniasis Market

20.1. Western Europe Visceral Leishmaniasis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Visceral Leishmaniasis Market, Segmentation By Treatment, Segmentation By Diagnosis Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Visceral Leishmaniasis Market

21.1. UK Visceral Leishmaniasis Market, Segmentation By Treatment, Segmentation By Diagnosis Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Visceral Leishmaniasis Market

22.1. Germany Visceral Leishmaniasis Market, Segmentation By Treatment, Segmentation By Diagnosis Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Visceral Leishmaniasis Market

23.1. France Visceral Leishmaniasis Market, Segmentation By Treatment, Segmentation By Diagnosis Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Visceral Leishmaniasis Market

24.1. Italy Visceral Leishmaniasis Market, Segmentation By Treatment, Segmentation By Diagnosis Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Visceral Leishmaniasis Market

25.1. Spain Visceral Leishmaniasis Market, Segmentation By Treatment, Segmentation By Diagnosis Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Visceral Leishmaniasis Market

26.1. Eastern Europe Visceral Leishmaniasis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Visceral Leishmaniasis Market, Segmentation By Treatment, Segmentation By Diagnosis Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Visceral Leishmaniasis Market

27.1. Russia Visceral Leishmaniasis Market, Segmentation By Treatment, Segmentation By Diagnosis Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Visceral Leishmaniasis Market

28.1. North America Visceral Leishmaniasis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Visceral Leishmaniasis Market, Segmentation By Treatment, Segmentation By Diagnosis Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Visceral Leishmaniasis Market

29.1. USA Visceral Leishmaniasis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Visceral Leishmaniasis Market, Segmentation By Treatment, Segmentation By Diagnosis Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Visceral Leishmaniasis Market

30.1. Canada Visceral Leishmaniasis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Visceral Leishmaniasis Market, Segmentation By Treatment, Segmentation By Diagnosis Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Visceral Leishmaniasis Market

31.1. South America Visceral Leishmaniasis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Visceral Leishmaniasis Market, Segmentation By Treatment, Segmentation By Diagnosis Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Visceral Leishmaniasis Market

32.1. Brazil Visceral Leishmaniasis Market, Segmentation By Treatment, Segmentation By Diagnosis Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Visceral Leishmaniasis Market

33.1. Middle East Visceral Leishmaniasis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Visceral Leishmaniasis Market, Segmentation By Treatment, Segmentation By Diagnosis Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Visceral Leishmaniasis Market

34.1. Africa Visceral Leishmaniasis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Visceral Leishmaniasis Market, Segmentation By Treatment, Segmentation By Diagnosis Method, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Visceral Leishmaniasis Market Regulatory and Investment Landscape

36. Visceral Leishmaniasis Market Competitive Landscape And Company Profiles

36.1. Visceral Leishmaniasis Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Visceral Leishmaniasis Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Visceral Leishmaniasis Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. GSK plc Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Sun Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Dr. Reddy's Laboratories Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Aurobindo Pharma Limited Overview, Products and Services, Strategy and Financial Analysis

37. Visceral Leishmaniasis Market Other Major And Innovative Companies

Cipla Limited, Zydus Lifesciences Limited, Glenmark Pharmaceuticals Limited, Alkem Laboratories Ltd., Xellia Pharmaceuticals, Gufic Biosciences Ltd., United Biotech Private Limited, DNDi, Sanofi SA, Bharat Serums and Vaccines Limited, Emcure Pharmaceuticals Limited, Hetero Drugs Limited, Lupin Limited, Ipca Laboratories Limited, Intas Pharmaceuticals Limited

38. Global Visceral Leishmaniasis Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Visceral Leishmaniasis Market

40. Visceral Leishmaniasis Market High Potential Countries, Segments and Strategies

40.1 Visceral Leishmaniasis Market In 2030 - Countries Offering Most New Opportunities

40.2 Visceral Leishmaniasis Market In 2030 - Segments Offering Most New Opportunities

40.3 Visceral Leishmaniasis Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Visceral Leishmaniasis Market, Overview Of Key Products - Product Examples
  • Table 2: Global Visceral Leishmaniasis Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Visceral Leishmaniasis Market, Supply Chain Analysis
  • Table 4: Global Visceral Leishmaniasis Market, Major Raw Material Providers
  • Table 5: Global Visceral Leishmaniasis Market, Major Resource Providers
  • Table 6: Global Visceral Leishmaniasis Market, Major Manufacturers (Suppliers)
  • Table 7: Global Visceral Leishmaniasis Market, Major Distributors And Channel Partners
  • Table 8: Global Visceral Leishmaniasis Market, Key Technologies & Future Trends
  • Table 9: Global Visceral Leishmaniasis Market, Major Trends
  • Table 10: Global Visceral Leishmaniasis Market, Major End Users
  • Table 11: Global Visceral Leishmaniasis Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Visceral Leishmaniasis Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Visceral Leishmaniasis Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Visceral Leishmaniasis Market - TAM, US$ Billion, 2025
  • Table 15: Global Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Visceral Leishmaniasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Visceral Leishmaniasis Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Visceral Leishmaniasis Market, Sub-Segmentation Of Antiparasitic, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Visceral Leishmaniasis Market, Sub-Segmentation Of Antifungal, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Visceral Leishmaniasis Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Visceral Leishmaniasis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Visceral Leishmaniasis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Global Visceral Leishmaniasis Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 98: Global Visceral Leishmaniasis Market - Company Scoring Matrix
  • Table 99: Pfizer Inc. Financial Performance
  • Table 100: GSK plc Financial Performance
  • Table 101: Sun Pharmaceutical Industries Ltd. Financial Performance
  • Table 102: Dr. Reddy's Laboratories Financial Performance
  • Table 103: Aurobindo Pharma Limited Financial Performance
  • Table 104: Global Visceral Leishmaniasis Market, Competitive Benchmarking (In USD Billions)
  • Table 105: Global Visceral Leishmaniasis Market, Competitive Dashboard
  • Table 106: Global Visceral Leishmaniasis Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 107: Global, Visceral Leishmaniasis Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030
  • Table 108: Global, Visceral Leishmaniasis Market Size Gain ($ Billion), Segmentation By Diagnosis Method, 2025 – 2030
  • Table 109: Global, Visceral Leishmaniasis Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

List Of Figures

    Figure 1: Global Visceral Leishmaniasis Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Visceral Leishmaniasis Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Visceral Leishmaniasis Market, Supply Chain Analysis
  • Figure 4: Global Visceral Leishmaniasis Market, Major Raw Material Providers
  • Figure 5: Global Visceral Leishmaniasis Market, Major Resource Providers
  • Figure 6: Global Visceral Leishmaniasis Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Visceral Leishmaniasis Market, Major Distributors And Channel Partners
  • Figure 8: Global Visceral Leishmaniasis Market, Key Technologies & Future Trends
  • Figure 9: Global Visceral Leishmaniasis Market, Major Trends
  • Figure 10: Global Visceral Leishmaniasis Market, Major End Users
  • Figure 11: Global Visceral Leishmaniasis Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Visceral Leishmaniasis Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Visceral Leishmaniasis Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Visceral Leishmaniasis Market - TAM, US$ Billion, 2025
  • Figure 15: Global Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Visceral Leishmaniasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Visceral Leishmaniasis Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Visceral Leishmaniasis Market, Sub-Segmentation Of Antiparasitic, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Visceral Leishmaniasis Market, Sub-Segmentation Of Antifungal, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Visceral Leishmaniasis Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Visceral Leishmaniasis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Visceral Leishmaniasis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Visceral Leishmaniasis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Visceral Leishmaniasis Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Visceral Leishmaniasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Global Visceral Leishmaniasis Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 98: Global Visceral Leishmaniasis Market - Company Scoring Matrix
  • Figure 99: Pfizer Inc. Financial Performance
  • Figure 100: GSK plc Financial Performance
  • Figure 101: Sun Pharmaceutical Industries Ltd. Financial Performance
  • Figure 102: Dr. Reddy's Laboratories Financial Performance
  • Figure 103: Aurobindo Pharma Limited Financial Performance
  • Figure 104: Global Visceral Leishmaniasis Market, Competitive Benchmarking (In USD Billions)
  • Figure 105: Global Visceral Leishmaniasis Market, Competitive Dashboard
  • Figure 106: Global Visceral Leishmaniasis Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 107: Global, Visceral Leishmaniasis Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030
  • Figure 108: Global, Visceral Leishmaniasis Market Size Gain ($ Billion), Segmentation By Diagnosis Method, 2025 – 2030
  • Figure 109: Global, Visceral Leishmaniasis Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Read More About Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Read More About CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

Read More About Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Read More About Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Visceral Pain Market Report 2026 - Global Outlook – By Drug Class (Calcium Channel Blockers, Nonsteroidal Anti-Inflammatory (NSAID), Other Drug Classes), By Indications (Interstitial Cystitis, Crohn’s, Irritable Bowel, C...

Anticoagulants Market Report 2026 - Global Outlook – By Drug Class (Factor Xa Inhibitor, Heparin And LMWH, Vitamin K Antagonist, Other Drug Classes), By Route Of Administration (Oral Anticoagulant, Injectable Anticoagula...

Psoriasis Market Report 2026 - Global Outlook – By Drug class (Interleukin Inhibitors, Corticosteroids, Anti-Inflammatory, Tumor Necrosis Factor Inhibitor), By Drug Types (Small molecules, Biologics  ), By Disease Indica...

Veterinary Parasiticides Market Report 2026 - Global Outlook – By Type (Endoparasiticides, Ectoparasiticides, Endectocides ), By Formulation (Oral Liquids, Tablets, Injectables, Sprays, Other Formulations), By Applicatio...

Bioceramics Market Report 2026 - Global Outlook – By Type (Bioinert, Bioactive, Bioresorbable), By Material (Aluminum Oxide, Zirconia, Calcium Phosphate, Other Materials), By Application (Orthopedic, Dental Implants, Bio...

Exosome Diagnostic And Therapeutic Market Report 2026 - Global Outlook – By Product (Instruments, Software, Reagents And Kits), By Application (Diagnostics, Therapeutic), By End User (Academic And Research Institutes, Ph...

Mucolipidosis II Market Report 2026 - Global Outlook – By Treatment (Antibiotics, Physical Therapy, Hip Replacement, Experimental Therapies, Other Treatments), By Mode Of Administration (Injectable, Oral, Other Modes Of ...

Systemic Aspergillosis And Systemic Candidiasis Market Report 2026 - Global Outlook – By Type (Systemic Oral Azoles, Voriconazole, Liposomal Amphotericin B, Topical Antifungal Agents, Other Types), By Application (Allerg...

Frequently Asked Questions

The Visceral Leishmaniasis market was valued at $1.06 billion in 2025, increased to $1.12 billion in 2026, and is projected to reach $1.39 billion by 2030.

The global Visceral Leishmaniasis market is expected to grow at a CAGR of 5.5% from 2026 to 2035 to reach $1.39 billion by 2035.

Some Key Players in the Visceral Leishmaniasis market Include, Pfizer Inc., GSK plc, Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories, Aurobindo Pharma Limited, Cipla Limited, Zydus Lifesciences Limited, Glenmark Pharmaceuticals Limited, Alkem Laboratories Ltd., Xellia Pharmaceuticals, Gufic Biosciences Ltd., United Biotech Private Limited, DNDi, Sanofi SA, Bharat Serums and Vaccines Limited, Emcure Pharmaceuticals Limited, Hetero Drugs Limited, Lupin Limited, Ipca Laboratories Limited, Intas Pharmaceuticals Limited, Macleods Pharmaceuticals Limited, Mankind Pharma Limited, Alembic Pharmaceuticals Limited .

Major trend in this market includes: Advancements In Oral Antiparasitic Therapies For Visceral Leishmaniasis. For further insights on this market. request a sample here

North America was the largest region in the visceral leishmaniasis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the visceral leishmaniasis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us